Altimmune Inc (ALT)
8.405
+0.36
(+4.41%)
USD |
NASDAQ |
Nov 21, 16:00
8.39
-0.02
(-0.18%)
After-Hours: 06:12
Altimmune Total Liabilities (Quarterly): 14.49M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.49M |
| June 30, 2024 | 20.82M |
| March 31, 2024 | 15.42M |
| December 31, 2023 | 16.54M |
| September 30, 2023 | 16.18M |
| June 30, 2023 | 15.60M |
| March 31, 2023 | 19.35M |
| December 31, 2022 | 21.64M |
| September 30, 2022 | 20.25M |
| June 30, 2022 | 15.37M |
| March 31, 2022 | 20.79M |
| December 31, 2021 | 19.73M |
| September 30, 2021 | 27.64M |
| June 30, 2021 | 15.98M |
| March 31, 2021 | 17.81M |
| December 31, 2020 | 19.24M |
| September 30, 2020 | 33.29M |
| June 30, 2020 | 23.02M |
| March 31, 2020 | 12.34M |
| December 31, 2019 | 8.538M |
| September 30, 2019 | 7.004M |
| June 30, 2019 | 5.751M |
| March 31, 2019 | 6.052M |
| December 31, 2018 | 6.438M |
| September 30, 2018 | 13.18M |
| Date | Value |
|---|---|
| June 30, 2018 | 15.78M |
| March 31, 2018 | 14.37M |
| December 31, 2017 | 14.35M |
| September 30, 2017 | 17.28M |
| June 30, 2017 | 14.87M |
| March 31, 2017 | 2.677M |
| December 31, 2016 | 6.193M |
| September 30, 2016 | 4.156M |
| June 30, 2016 | 3.680M |
| March 31, 2016 | 3.108M |
| December 31, 2015 | 3.213M |
| September 30, 2015 | 3.224M |
| June 30, 2015 | 4.280M |
| March 31, 2015 | 5.442M |
| December 31, 2014 | 3.704M |
| September 30, 2014 | 5.244M |
| June 30, 2014 | 4.359M |
| March 31, 2014 | 6.049M |
| December 31, 2013 | 9.804M |
| September 30, 2013 | 9.265M |
| June 30, 2013 | 11.37M |
| March 31, 2013 | 12.03M |
| December 31, 2012 | 11.07M |
| September 30, 2012 | 10.86M |
| June 30, 2012 | 10.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.538M
Minimum
Dec 2019
33.29M
Maximum
Sep 2020
18.70M
Average
18.53M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Viking Therapeutics Inc | 26.44M |
| Amgen Inc | 83.36B |
| Avid Bioservices Inc | 276.01M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 147.86M |
| Shareholders Equity (Quarterly) | 133.38M |
| Current Ratio | 16.87 |